Phospholipase A2 enzymes

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 3-58

  Kudo, Ichiro ^a   Murakami, Makoto ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Arachidonic acid; Eicosanoids; Phospholipase A2

Indexed keywords

ANNEXIN; APC PROTEIN; ARACHIDONIC ACID; BROMOENOL LACTONE; CALCIUM ION; GLYCEROPHOSPHOLIPID; HYDROLASE; ICOSANOID; ISOENZYME; LEUKOTRIENE; LIPID; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPID DERIVATIVE; PROSTAGLANDIN DERIVATIVE; SECRETORY PROTEIN; SERUM AMYLOID A; THROMBOCYTE ACTIVATING FACTOR; CALCIUM; MEMBRANE LIPID; PHOSPHOLIPASE A;

ANTICOAGULATION; ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BRAIN INJURY; CANCER; CATALYSIS; CELL PROLIFERATION; CYTOSOL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; EXOCYTOSIS; HOST RESISTANCE; HUMAN; HYDROLYSIS; INFLAMMATION; LIPID DEGRADATION; LIPID TRANSPORT; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; ANIMAL; ARTERIOSCLEROSIS; BLOOD CLOTTING; BRAIN; CHEMISTRY; CLASSIFICATION; ENZYME ACTIVE SITE; FEMALE; GENETICS; ISCHEMIA; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; REVIEW;

ANIMALS; ARACHIDONIC ACID; ARTERIOSCLEROSIS; BLOOD COAGULATION; BRAIN; CALCIUM; CATALYTIC DOMAIN; EXOCYTOSIS; FEMALE; HUMANS; INFLAMMATION; ISCHEMIA; ISOENZYMES; MEMBRANE LIPIDS; NEOPLASMS; PHOSPHOLIPASES A; PREGNANCY;

EID: 0036669210     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00020-5     Document Type: Article

References (355)

1. 2. Rev. Physiol. Biochem. Pharmacol. 91:1981;91.
2. 2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA. 5:1986;519.
3. 2. J. Biochem. (Tokyo). 106:1989;545.
4. 2. J. Biol. Chem. 264:1989;5768.
5. 2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:1989;5335.
6. 2. J. Biol. Chem. 269:1994;13057.
7. 2 enzymes, classification and characterization. Biochim. Biophys. Acta. 1488:2000;1.
8. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043.
9. 2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266:1991;5268.
10. 2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269.
11. 2s containing 16 cysteines. J. Biol. Chem. 269:1994;23018.
12. 2. J. Biol. Chem. 269:1994;2365.
13. 2. J. Biol. Chem. 272:1997;15745.
14. 2s. J. Biol. Chem. 274:1999;24973.
15. 2. J. Biol. Chem. 274:1999;19152.
16. 2: cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J. Biol. Chem. 274:1999;31195.
17. 2s. J. Biol. Chem. 275:2000;5785.
18. 2. Biochem. Biophys. Res. Commun. 279:2000;223.
19. 2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275:2000;7492.
20. 2. J. Biol. Chem. 275:2000;39823.
21. 2s preferentially expressed in type 2 helper T cells. J. Biol. Chem. 276:2001;18321.
22. 2. J. Biol. Chem. 273:1998;21926.
23. 2. J. Biol. Chem. 274:1999;8823.
24. 2-β J. Biol. Chem. 274:1999;17063.
25. 2 contains eight ankyrin motifs. J. Biol. Chem. 272:1997;8567.
26. 1 macrophages and Chinese hamster ovary cells. J. Biol. Chem. 272:1997;8576.
27. 2 and their effect on enzyme activity. J. Biol. Chem. 273:1998;207.
28. 2 gene on chromosome 22q13.1. J. Biol. Chem. 274:1999;9607.
29. 2 gene: multiple enzymes with distinct properties from a single gene. Eur. J. Biochem. 262:1999;575.
30. 2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1997;1.
31. 2. J. Biol. Chem. 275:2000;9937.
32. 2. Biochem. Biophys. Res. Commun. 272:2000;320.
33. Stafforini D.M., McIntyre T.M., Zimmerman G.A., Prescott S.M. Platelet-activating factor acetylhydrolases. J. Biol. Chem. 272:1997;17895.
34. Tjoelker L.W., Wilder C., Eberhardt C., Stafforini D.M., Dietsch G., Schimpf B.et al. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374:1995;549.
35. Hattori K., Adachi H., Matsuzawa A., Yamamoto K., Tsujimoto M., Aoki J.et al. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II: its homology with plasma PAF acetylhydrolase. J. Biol. Chem. 271:1996;33032.
36. Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K. The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase. J. Biol. Chem. 269:1994;23150.
37. Hattori M., Adachi H., Aoki J., Tsujimoto M., Arai H., Inoue K. Cloning and expression of a cDNA encoding the β-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 270:1995;31345.
38. Adachi H., Tsujimoto M., Hattori M., Arai H., Inoue K. cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase γ-subunit and its mRNA expression in human tissues. Biochem. Biophys. Res. Commun. 214:1995;180.
39. 2 and their receptors and binding proteins. Biochim. Biophys. Acta. 1488:2000;59.
40. 2 from inflammatory exudate. Science. 254:1991;1007.
41. 2 at 2.2 Å resolution. Nature. 352:1991;79.
42. 2 gene family in mammals. J. Biol. Chem. 272:1997;17247.
43. 2 induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem. 274:1999;34203.
44. 2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J. Biol. Chem. 271:1996;30041.
45. 2. J. Biol. Chem. 273:1998;14411.
46. 2. J. Biol. Chem. 268:1993;839.
47. 2 with the glycosyl phosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid biosynthetic pathway. J. Biol. Chem. 274:1999;29927.
48. 2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276:2001;10083.
49. 2 secreted and anchored on cell-surface heparan sulfate proteoglycan. Eur. J. Biochem. 218:1993;807.
50. 2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273:1998;1733.
51. 2s in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechamism independent of their enzymatic functions. J. Immunol. 161:1998;5008.
52. 2 on cell membranes: vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme. J. Biol. Chem. 273:1998;32142.
53. 2. Biochim. Biophys. Acta. 1170:1993;217.
54. 2. Crit. Rev. Immunol. 17:1997;225.
55. 2s. Adv. Immunol. 77:2000;163.
56. 2 but not groups IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275:2000;3179.
57. 2. Biochemistry. 36:1997;14325.
58. 2 as a result of interfacial activation by specific anions: potential role of cholesterol sulphate. Biochem. J. 308:1995;507.
59. 2. J. Biol. Chem. 274:1999;11881.
60. 2s in regulating arachidonic acid release and prostaglandin generation: implication of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation. J. Biol. Chem. 274:1999;31435.
61. 2; electrostatically neutral interface binding surface targets zwitterionic membranes. J Biol Chem 2002, in press.
62. 2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes. Biochemistry. 37:1998;13203.
63. 2 type II to proteoglycans: differential effect of glycosaminoglycans on enzyme activity. J. Biol. Chem. 271:1996;26307.
64. 2 by sphingomyelin and annexin VI. Biochem. J. 326:1997;227.
65. 2. Biochem. J. 336:1998;625.
66. 2 to hydrolyze membrane phospholipids in rabbit platelets. J. Biochem. (Tokyo). 122:1997;859.
67. 2s and lipid peroxidation. Biochim. Biophys. Acta. 1488:2000;167.
68. 2 from guinea pig gastric mucosa, its induction by carbachol and secretion in vivo. Eur. J. Biochem. 215:1993;91.
69. 2 isoforms in rat kidney: their role in eicosanoid synthesis. Biochim. Biophys. Acta. 1257:1995;11.
70. 2. J. Biol. Chem. 263:1998;5724.
71. 2 into receptor binding, active forms. Biochem. Biophys. Res. Commun. 198:1994;10.
72. 2 in pancreatic beta cells. Regulation of mRNA levels by starvation or glucose excess. FEBS Lett. 295:1991;110.
73. 2. J. Clin. Invest. 95:1995;603.
74. 2 and cryptdin by rat small intestinal Paneth cells. Infect. Immun. 64:1996;5161.
75. 2 in mononuclear phagocytic cells in rat spleen and liver. Eur. J. Biochem. 197:1991;323.
76. 2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion. Biochem. J. 293:1993;143.
77. 2 and lysophosphatidylserine-specific lysophospholipase from rat platelets. J. Biochem. (Tokyo). 101:1987;53.
78. 2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J. Biol. Chem. 265:1990;6675.
79. 2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur. J. Biochem. 209:1992;257.
80. 2: a mediator between proximal and distal effectors of inflammation. Immunol. Today. 12:1991;143.
81. 2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut. 35:1994;1593.
82. 2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett. 273:1990;23.
83. 2 production by blocking mRNA synthesis and post-transcriptional expression. J. Biol. Chem. 265:1990;12745.
84. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266:1991;2647.
85. 2 in rat cultured astrocytes: two distinct pathways of the gene expression. J. Biol. Chem. 266:1991;9956.
86. 2 in arachidonic acid metabolism. Adv. Exp. Med. Biol. 469:1999;183.
87. 2 by rat mesangial cells: its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J. Clin. Invest. 92:1993;2516.
88. 2. J. Immunol. 165:2000;4024.
89. 2 gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process. J. Biol. Chem. 274:1999;23085.
90. 2 in human arterial smooth muscle cells: involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J. Biol. Chem. 275:2000;22895.
91. 2 expression in rat gastric epithelial cells. J. Biol. Chem. 276:2001;21854.
92. 2 activity and protein synthesis is blocked by dexamethasone in rat mesangial cells. FEBS Lett. 333:1993;339.
93. 2 gene expression by interleukin 1 and forskolin in mesangial cells. FEBS Lett. 291:1991;249.
94. 2. J. Biol. Chem. 267:1992;8846.
95. 2 in rat renal mesangial cells. FEBS Lett. 364:1995;218.
96. 2 gene transcription by interleukin-1β: role of C/EBP factors. J. Biol. Chem. 275:2000;22686.
97. Min-induced intestinal neoplasia. Cell. 81:1995;957.
98. 2 expression and function by proinflammatory stimuli. Eur. J. Biochem. 263:1999;826.
99. 2 gene in inbred mouse strains. J. Biol. Chem. 270:1995;22378.
100. 2 family, is associated with lymphotoxin deficiency. Genes Immun. 1:2000;191.
101. 2. J Biol Chem 2002;277:19145.
102. 2 that mediates prostaglandin production in mast cells. J. Biol. Chem. 272:1997;13591.
103. 1 macrophages. J. Biol. Chem. 271:1996;32381.
104. 2. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7951.
105. 2-dependent induction of cyclooxygenase-2 in macrophages. J. Biol. Chem. 274:1999;25967.
106. 2s. J. Biol. Chem. 274:1999;12263.
107. 2 in rat mesangial cells. Biochim. Biophys. Acta. 1484:2000;215.
108. 2 in cultured rat astrocytes. J. Biol. Chem. 275:2000;10876.
109. 2 and cyclooxygenase-2 in activated human keratinocytes. Am. J. Physiol. Cell Physiol. 278:2000;C822.
110. 2 enzymes have different intracellular locations in mouse bone marrow-derived mast cells. J. Biol. Chem. 274:1999;31476.
111. 2: quantitative analysis of expression and secretion and determination of the localization and routing in rat mesangial cells. Biochim. Biophys. Acta. 1530:2001;86.
112. 2 formation during colon tumorigenesis. FEBS Lett. 487:2000;262.
113. 2 as the major enzyme secreted by human keratinocytes and its regulation by the phorbol ester TPA. J. Invest. Dermatol. 116:2001;31.
114. 1 cells. J. Biol. Chem. 268:1993;21875.
115. 2. J. Biol. Chem. 272:1997;19891.
116. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274:1999;3103.
117. 2 added exogenously. J. Biochem. (Tokyo). 110:1991;163.
118. 2. FEBS Lett. 294:1991;247.
119. 2. J. Biol. Chem. 274:1999;11494.
120. 2 in human erythrocytes. J. Biol. Chem. 276:2001;22732.
121. 2 activates human platelets. Biochem. J. 327:1997;259.
122. Galbiati F., Razani B., Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell. 106:2001;403.
123. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1993;1023.
124. Mertens G., van der Schueren B., van den Berghe H., David G. Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content. J. Cell Biol. 132:1996;487.
125. Liang Y., Haring M., Roughley P.J., Margolis R.K., Margolis R.U. Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J. Cell Biol. 139:1997;851.
126. 2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes. Arterioscler. Thromb. Vasc. Biol. 18:1998;1934.
127. 2. FEBS Lett. 453:1999;81.
128. 1 macrophages via sphingomyelin synthesis. J. Biol. Chem. 272:1997;20373.
129. 2 in arachidonic acid release from human neutrophils. J. Immunol. 164:2000;2084.
130. 2. Biochem Biophys Res Commun 2002;292:689.
131. 2 acts on the perinuclear membranes. J Biol Chem 2002;277:9358.
132. 2 in mast cells. Biochem. Biophys. Res. Commun. 276:2000;667.
133. 2 internalization and degradation. J. Biol. Chem. 276:2001;11126.
134. 2 receptor. Arch. Biochem. Biophys. 381:2000;31.
135. 2 synthesis in mast cells. J. Immunol. 165:2000;4007.
136. 2: molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J. Biol. Chem. 270:1995;8963.
137. 2. Trends. Pharmacol. Sci. 20:1999;162.
138. 2 in rat renal mesangial cells. Biochim. Biophys. Acta. 1348:1997;257.
139. 2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273:1998;606.
140. 2 in murine bone marrow-derived mast cells. J. Immunol. 165:2000;2773.
141. 2 expression and prostaglandin biosynthesis in rat mesangial cells. J. Biol. Chem. 269:1994;5092.
142. 2 are natural ligands of the mouse 180-kDa M-type receptor. J. Biol. Chem. 274:1999;7043.
143. 2 receptor-deficient mice. J. Biol. Chem. 272:1997;32792.
144. 2 and distal prostaglandin synthase 1. J. Biol. Chem. 271:1996;186.
145. 2s. J. Biol. Chem. 276:2001;34918.
146. 2-activating protein. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5418.
147. 2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. J. Lab. Clin. Med. 116:1990;814.
148. 2 activating protein (PLAP) and melittin. Biochim. Biophys. Acta. 1166:1993;124.
149. 2-activating protein. Biochim. Biophys. Acta. 1444:1999;125.
150. 2-activating protein and by activation of phospholipase C and D. J. Biol. Chem. 276:2001;5467.
151. 2 for phosphatidic acid. Biochem. J. 321:1997;737.
152. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:1995;919.
153. 2 to liberate arachidonic acid. Biochim. Biophys. Acta. 1349:1997;43.
154. 2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells. Biochem. Biophys. Res. Commun. 181:1991;714.
155. 2-deficient mice. Gastroenterology. 120:2001;1193.
156. Takemori H., Zolotaryov F.N., Ting L., Urbain T., Komatsubara T., Hatano O.et al. Identification of functional domains of rat intestinal phospholipase B/lipase: its cDNA cloning, expression, and tissue distribution. J. Biol. Chem. 273:1998;2222.
157. 2 in concert with polymorphonuclear leukocytes. J. Biol. Chem. 269:1994;26331.
158. 2. J. Clin. Invest. 97:1996;250.
159. 2. J. Clin. Invest. 102:1998;633.
160. 2 against Gram-positive bacteria. J. Clin. Invest. 103:1999;715.
161. 2 is the principal bactericide for Staphylococci and other Gram-positive bacteria in human tears. Infect. Immun. 66:1998;2791.
162. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97:1996;2233.
163. 2 against Staphylococcus aureus. J. Immunol. 162:1999;7402.
164. 2 to Escherichia coli infection. Infect. Immun. 68:2000;87.
165. 2. J Biol Chem 2002;277:5849.
166. 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem. J. 318:1996;701.
167. 2. J. Immunol. 151:1993;5675.
168. Karli U.O., Schafer T., Burger M.M. Fusion of neurotransmitter vesicles with target membrane is calcium independent in a cell-free system. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5912.
169. 2. J. Biol. Chem. 262:1987;14402.
170. 2 on cell-free prothrombinase complex. J. Biol. Chem. 269:1994;26338.
171. 2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va. Eur. J. Biochem. 237:1996;778.
172. 2 involves binding to factor Xa. J. Biol. Chem. 273:1998;23764.
173. 2. Eur. J. Biochem. 267:2000;4960.
174. Yokoyama K., Kudo I., Inoue K. Phospholipid degradation in rat calcium ionophore-activated platelets is catalyzed mainly by two discrete secretory phospholipase As. J. Biochem. (Tokyo). 117:1995;1280.
175. 2. FEBS Lett. 268:1990;113.
176. 2 induces an inflammatory response in rabbit joints. J. Immunol. 146:1991;3904.
177. 2 in the inflammatory process of carrageenan-induced pleurisy in rats. FEBS Lett. 339:1994;76.
178. 2 inhibitor. J. Pharmacol. Exp. Ther. 278:1996;252.
179. 2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection. Crit. Care Med. 29:2001;719.
180. 2 protein interaction. J. Clin. Invest. 102:1998;1152.
181. Cormier R.T., Hong K.H., Halberg R.B., Hawkins T.L., Richardson P., Mulherkar R.et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 17:1997;88.
182. Kikuchi-Yanoshita R., Yanoshita R., Kudo I., Arai H., Takamura T., Nomoto K.et al. Preferential hydrolysis of phosphatidylethanolamine in rat ischemic heart homogenates during in vitro incubation. J. Biochem. (Tokyo). 114:1993;33.
183. 2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am. J. Physiol. 268:1995;G397.
184. 2 prevent renal injury due to ischemia and reperfusion in rats. FEBS Lett. 440:1998;377.
185. 2 in rat brain after severe forebrain ischemia and in endotoxin shock. Brain Res. 651:1994;353.
186. 2. Arterioscler. Thromb. Vasc. Biol. 19:1999;1284.
187. 2 in atherosclerosis. Part 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 19:1999;1291.
188. 2 causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J. Biol. Chem. 275:2000;10077.
189. 2 expression in human aortic tissue in dependence on the degree of atherosclerosis. Atherosclerosis. 144:1999;73.
190. 2 and decorin in human atherosclerotic lesions. Circ Res. 86:2000;707.
191. 2. Biochem. J. 309:1995;461.
192. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803.
193. 2 gene alterations in human colorectal cancer. Cancer Res. 55:1995;5184.
194. Nimmrich I., Friedl W., Kruse R., Pietsch S., Hentsch S., Deuter R.et al. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Hum. Genet. 100:1997;345.
195. 2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res. 58:1998;500.
196. 2 in malignant and non-malignant human gastric mucosa. Br. J. Cancer. 68:1993;103.
197. 2 in human hepatocellular carcinoma. Biochim. Biophys. Acta. 1226:1994;201.
198. 2 are produced in human pancreatic cancer cells and influence prognosis. Gut. 45:1999;605.
199. 2 generates anti-apoptotic survival signals in kidney fibroblasts. J. Biol. Chem. 274:1999;27726.
200. Zhou Q., Zhao J., Stout J.G., Luhm R.A., Wiedmer T., Sims P.J. Molecular cloning of human plasma membrane phospholipid scramblase: a protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 272:1997;18240.
201. Zhao J., Zhou Q., Wiedmer T., Sims P.J. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J. Biol. Chem. 273:1998;6603.
202. 2 gene. J. Biol. Chem. 275:2000;34013.
203. 2 is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur J Biochem 2002;269:2698.
204. 2 expressed in insect cells and present in human monocytes. J. Biol. Chem. 271:1996;6987.
205. 2 in agonist-stimulated human platelets and HeLa cells. J. Biol. Chem. 273:1998;4449.
206. 2 by MNK1-related protein kinases. J. Biol. Chem. 275:2000;37542.
207. 2. J Biol Chem 2001;276:39653.
208. 2 gene. Nucleic Acids Res. 23:1995;293.
209. 3 cells. J. Biol. Chem. 276:2001;7136.
210. Ponting C.P., Parker P.J. Extending the C2 domain family: C2s in PKCs delta, epsilon, eta, theta, phospholipases, GAPs, and perforin. Protein Sci. 5:1996;162.
211. 2. J. Biol. Chem. 274:1999;14979.
212. 2. J. Mol. Biol. 280:1998;485.
213. 2. J. Biol. Chem. 273:1998;1365.
214. 2: identification of essential calcium ligands and hydrophobic membrane binding residues. J. Biol. Chem. 274:1999;9665.
215. 2 enzymes on product-containing vesicles: application to the determination of substrate preferences. Biochemistry. 32:1993;5949.
216. 2 on anionic vesicles in the scooting model. Biochemistry. 36:1997;11366.
217. 2. Biochemistry. 37:1998;8516.
218. 2 control functional specificity. J. Biol. Chem. 276:2001;32288.
219. 2: probing the role of histidine, aspartic acid, cysteine, and arginine. J. Biol. Chem. 271:1996;19225.
220. 2 by p42 mitogen-activated protein kinase results in an increase in specific activity. Eur. J. Biochem. 238:1996;690.
221. 2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab. Invest. 74:1996;684.
222. 2 in a mixed vesicle model. J. Biol. Chem. 267:1992;18342.
223. 2 that exhibits lysophospholipase activity. J. Biol. Chem. 266:1991;11366.
224. 2. Eur. J. Biochem. 218:1993;629.
225. 2. Biochim. Biophys. Acta. 1167:1993;272.
226. 2. J. Biol. Chem. 272:1997;19214.
227. 2+-independent catalytic domain. J. Biol. Chem. 269:1994;18239.
228. 2. J. Biol. Chem. 272:1997;16709.
229. 2. Biochim. Biophys. Acta. 1488:2000;123.
230. 2 correlate with lymphocyte maturation. J. Immunol. 156:1996;2054.
231. 2 in human fibroblasts. J. Biol. Chem. 267:1992;23451.
232. 2. EMBO J. 11:1992;4917.
233. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4475.
234. 2 in glomerular mesangial cells. Biochem. J. 295:1993;763.
235. ε-receptor. J. Immunol. 153:1994;796.
236. 2. J. Clin. Invest. 93:1994;571.
237. 2 gene expression in human bronchial epithelial cells. Biochim. Biophys. Acta. 1310:1996;175.
238. 2 generation in immature mouse mast cells. J. Biol. Chem. 270:1995;3239.
239. 4 pathway in mouse mast cells. J. Biol. Chem. 270:1995;22653.
240. 2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration. Biochem. J. 313:1996;91.
241. 2 gene expression in cultured human bronchial epithelial cells. Biochim. Biophys. Acta. 1355:1997;121.
242. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60:1997;67.
243. 2 gene. Nucleic Acids Res. 22:1994;5093.
244. 2). Biochim. Biophys. Acta. 1217:1994;345.
245. 2 in allergic response and parturition. Nature. 390:1997;618.
246. 2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271:2000;812.
247. 2 in the production of lipid mediators and histamine release in mouse bone marrow-derived mast cells. Biochem. J. 352:2000;311.
248. 2. Nature. 390:1997;622.
249. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4803.
250. 2 regulation. J. Biol. Chem. 275:2000;20146.
251. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270:1995;30749.
252. 2. J. Cell Biol. 145:1999;1219.
253. 2. J. Biol. Chem. 274:1999;5163.
254. 2 translocation to internal membranes. J. Biol. Chem. 276:2001;30150.
255. 2. Eur. J. Biochem. 265:1999;957.
256. Rhee S.G. Rgulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70:2001;281.
257. 2 binds with high affinity and specificity to phosphatidylinositol-4,5-bisphosphate resulting in dramatic increases in activity. J. Biol. Chem. 273:1998;2184.
258. 2 by phosphatidylinositol bisphosphate levels. J. Immunol. 164:2000;5398.
259. 2 J Biol Chem 2002;277:23838.
260. Sekiya F., Bae Y.S., Jhon D.Y., Hwang S.C., Rhee S.G. AHNAK, a protein that binds and activates phospholipase C-γ1 in the presence of arachidonic acid. J. Biol. Chem. 274:1999;13900.
261. 2 in leukocyte cell lines. J. Immunol. 163:1999;5462.
262. 1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. J. Immunol. 164:2000;4089.
263. 2/cyclooxygenase-2-mediated prostaglandin biosynthetic pathways. FEBS Lett. 475:2000;242.
264. 2 from cytosol to membranes in platelets. Arch. Biochem. Biophys. 382:2000;296.
265. 2 and facilitates its membrane docking and arachidonic acid release. FASEB J. 15:2001;7.
266. 2 is induced by ATP depletion. J. Biol. Chem. 276:2001;29899.
267. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1993;1960.
268. 2 phosphorylation and eicosanoid production by colony-stimulating factor-1. J. Biol. Chem. 269:1994;31693.
269. 2. J. Biol. Chem. 271:1996;27723.
270. 2 in regulating arachidonic acid release in macrophages. J. Biol. Chem. 273:1998;8203.
271. 2 independent of the mitogen-activated protein kinases ERK1/2. J. Biol. Chem. 270:1995;14816.
272. 2 by transforming growth factor-α in HEL-30 keratinocytes. J. Biol. Chem. 268:1993;16795.
273. 2 is required for the formation of interferon-stimulated gene factor three. EMBO J. 15:1996;1566.
274. 2α J. Biol. Chem. 275:2000;1161.
275. 2. J. Biol. Chem. 272:1997;17145.
276. 2 activity. J. Biol. Chem. 274:1999;17202.
277. 2 under the control of p11 in rat gastric epithelial cells. Br. J. Pharmacol. 131:2000;1004.
278. 2 by lipocortins and calpactins: an effect of binding to substrate phospholipids. J. Biol. Chem. 262:1987;1698.
279. 2 activity: specific interaction model. FEBS Lett. 489:2001;243.
280. 2 by annexin I: specific interaction model and mapping of the interaction site. J. Biol. Chem. 276:2001;15712.
281. 2+-binding site in the mechanism of inhibition. J. Biol. Chem. 272:1997;10474.
282. 2, induces apoptosis, and potentiates prostaglandin production. Mol. Cell. Biol. 21:2001;4470.
283. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268:1993;11290.
284. 2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J. Biol. Chem. 271:1996;21505.
285. 2 in human melanoma tumor cells. J. Immunol. 156:1996;201.
286. Nagata S. Apoptosis by death factor. Cell. 88:1997;355.
287. 2 is not involved in Fas-mediated apoptosis. Eur. J. Biochem. 236:1996;533.
288. 2 which undergoes proteolytic inactivation. J. Biol. Chem. 273:1998;13870.
289. 2 during apoptosis. J. Immunol. 161:1998;5687.
290. 2 augments spontaneous fatty acid release. J. Biol. Chem. 275:2000;18248.
291. 2 by caspase-1 (ICE) and caspase-8 (FLICE). Biochem. Biophys. Res. Commun. 253:1998;92.
292. 2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras isoform. J. Biol. Chem. 276:2001;24645.
293. 2 by oncogenic Ras in human non-small cell lung cancer. J. Biol. Chem. 272:1997;14501.
294. 2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J. Biol. Chem. 276:2001;1226.
295. 2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273:1998;441.
296. + channel in phagocyte-like cells. J. Biol. Chem. 274:1999;21603.
297. 2-linked cascade. J. Biol. Chem. 275:2000;32357.
298. 2 reveals a novel topology and catalytic mechanism. Cell. 97:1999;349.
299. Irvin C.G., Tu Y.P., Sheller J.R., Funk C.D. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol. 272:1997;L1053.
300. 2 as a mediator of allergic asthma. Science. 287:2000;2013.
301. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S.et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187:1998;1779.
302. 2. Nat. Immunol. 1:2000;42.
303. 2 messenger RNA mainly in neurons in the rat brain. Neuroscience. 92:1999;1061.
304. 2 are resistant to MPTP neurotoxicity. J. Neurochem. 71:1998;2634.
305. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E.et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1294.
306. Gross G.A., Imamura T., Luedke C., Vogt S.K., Olson L.M., Nelson D.M.et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11875.
307. Sugimoto Y., Yamasaki A., Segi E., Tsuboi K., Aze Y., Nishimura T.et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 277:1997;681.
308. 2 as defined by gene knockouts. Biochim. Biophys. Acta. 1488:2000;139.
309. Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M.et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 91:1997;197.
310. 2 receptor. Nat. Med. 5:1999;217.
311. 2. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10501.
312. Min-induced tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3935.
313. Δ716 knockout mice. Nat. Med. 7:2001;1048.
314. 3. Gastroenterology. 117:1999;1128.
315. 2. Am. J. Physiol. Renal Physiol. 280:2001;F607.
316. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C.et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:1995;483.
317. Myer L.K., Postlethwaite A.E., Rosloniec E.F., Morham S.G., Splopov B.V., Goorha S.et al. The genetic ablation of cyclooxygenase-2 prevents the development of autoimmune arthritis. Arthritis Rhem. 43:2000;2687.
318. 4 subtype. Infect. Immun. 68:2000;6819.
319. 2 modulates tumor mecrosis factor-α- and interleukin-1β-induced NF-κB activation. J. Biol. Chem. 276:2001;30527.
320. 2 enzymes. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11060.
321. 1 macrophages. J. Biol. Chem. 271:1996;6758.
322. 2β: implications for structure and function. J. Biol. Chem. 276:2001;7129.
323. Sedgwick S.G., Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24:1999;311.
324. 1 cells: isolation and characterization. J. Biol. Chem. 269:1994;9227.
325. 2. Biochim. Biophys. Acta. 1392:1998;320.
326. 1 cells. J. Biol. Chem. 274:1999;19906.
327. 2β J. Biol. Chem. 276:2001;13198.
328. 1 macrophages. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8527.
329. 1 macrophages. J. Biol. Chem. 271:1996;31937.
330. 2: structure and function. Biochim. Biophys. Acta. 1488:2000;28.
331. 1 macrophages. J. Biol. Chem. 272:1997;29317.
332. Baburina I., Jackowski S. Cellular responses to excess phospholipid. J. Biol. Chem. 274:1999;9400.
333. 2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells. J. Biol. Chem. 274:1999;13915.
334. 2: a novel mechanism underlying arachidonic acid mobilization. J. Biol. Chem. 272:1997;1522.
335. 2 mediates lymphocyte proliferation. J. Biol. Chem. 275:2000;35692.
336. 2 with a catalytic triad. J. Biol. Chem. 270:1995;25481.
337. Min J.H., Wilder C., Aoki J., Arai H., Inoue K., Paul L.et al. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme. Biochemistry. 40:2001;4539.
338. 2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase. Biochem. J. 329:1998;41.
339. Stafforini D.M., Tjoelker L.W., McCormick S.P., Vaitkus D., McIntyre T.M., Gray P.W.et al. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J. Biol. Chem. 274:1999;7018.
340. Miwa M., Miyake T., Yamanaka T., Sugatani J., Suzuki Y., Sakata S.et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1998;1983.
341. Stafforini D.M., Satoh K., Atkinson D.L., Tjoelker L.W., Eberhardt C., Yoshida H.et al. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97:1996;2784.
342. Nakajima K., Murakami M., Yanoshita R., Samejima Y., Karasawa K., Setaka M.et al. Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor. J. Biol. Chem. 272:1997;19708.
343. Cao Y., Stafforini D.M., Zimmerman G.A., McIntyre T.M., Prescott S.M. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J. Biol. Chem. 273:1998;4012.
344. Howard K.M., Miller J.E., Miwa M., Olson M.S. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J. Biol. Chem. 272:1997;27543.
345. Howard K.M., Olson M.S. The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. J. Biol. Chem. 275:2000;19891.
346. Hattori K., Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K. Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol. J. Biol. Chem. 270:1995;22308.
347. Matsuzawa A., Hattori K., Aoki J., Arai H., Inoue K. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor acetylhydrolase II. J. Biol. Chem. 272:1997;32315.
348. 2 ceramide. J. Biol. Chem. 274:1999;8655.
349. Bae K., Longobardi L., Karasawa K., Malone B., Inoue T., Aoki J.et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. J. Biol. Chem. 275:2000;26704.
350. Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K. Miller-Deicker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature. 370:1994;216.
351. Ho Y.S., Swenson L., Derewenda U., Serre L., Wei Y., Dauter Z.et al. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature. 385:1997;89.
352. Mannya H., Aoki J., Kato H., Ishii J., Hino S., Arai H.et al. Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 274:1999;31827.
353. Mannya H., Aoki J., Watanabe M., Adachi T., Asou H., Inoue Y.et al. Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. J. Biol. Chem. 273:1998;18567.
354. Sapir T., Cahana A., Seger R., Nekhai S., Reiner O. LIS1 is a microtubule-associated phosphoprotein. Eur. J. Biochem. 265:1999;181.
355. Kato K., Clark G.D., Bazan N.G., Zorumski C.F. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature. 367:1994;175.